In non-tumor bearing animals, VEGFR1 activation inhibits stem cell differentiation to the dendritic cell lineage whereas VEGFR2 activation decreases the number and function of mature dendritic cells in the spleen [17]. This evidence concerns the gene KDR and neoplasm.